ICU Medical: record Q3 2026 sales and 20% adjusted EPS growth
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Release Date: November 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ICU Medical Inc (NASDAQ:ICUI) reported strong Q3 2026 revenue of $556 million…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishSolid quarterly results with strong cash flow and debt reduction, relevant for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 2026 revenue was $556 million, with 5% organic growth.
- 02Adjusted EPS rose 20% to $2.44 and adjusted EBITDA rose 8% to $114 million.
- 03Free cash flow of $83 million enabled an $80 million debt repayment.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets